Cargando…

Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy

Cyclins/retinoblastoma protein (pRb) pathway participates in cardiomyocyte hypertrophy. MicroRNAs (miRNAs), the endogenous small non-coding RNAs, were recognized to play significant roles in cardiac hypertrophy. But, it remains unknown whether cyclin/Rb pathway is modulated by miRNAs during cardiac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Shuai, Zou, Xiao, Zhu, Jie-Ning, Fu, Yong-Heng, Lin, Qiu-Xiong, Liang, Ye-You, Deng, Chun-Yu, Kuang, Su-Juan, Zhang, Meng-Zhen, Liao, Yu-Lin, Zheng, Xi-Long, Yu, Xi-Yong, Shan, Zhi-Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369817/ https://www.ncbi.nlm.nih.gov/pubmed/25583328 http://dx.doi.org/10.1111/jcmm.12445

Ejemplares similares

Immune-mediated neurodegenerative trait provoked by multimodal derepression of long-interspersed nuclear element-1
por: Takahashi, Fumio, et al.
Publicado: (2022)

Pyrazole-Curcumin Suppresses Cardiomyocyte Hypertrophy by Disrupting the CDK9/CyclinT1 Complex
por: Funamoto, Masafumi, et al.
Publicado: (2022)

MicroRNA-16 Inhibits Glioblastoma Growth in Orthotopic Model by Targeting Cyclin D1 and WIP1
por: Wang, Heng, et al.
Publicado: (2020)

Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma
por: Lin, Ho-Sheng, et al.
Publicado: (2006)

METTL16 promotes cell proliferation by up‐regulating cyclin D1 expression in gastric cancer
por: Wang, Xiao‐Kun, et al.
Publicado: (2021)

SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy
por: Shen, Tao, et al.
Publicado: (2014)

Expression of Cyclin D1 and P16 in Esophageal Squamous Cell Carcinoma
por: Dey, Biswajit, et al.
Publicado: (2015)

Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis
por: Knudsen, Karen E.
Publicado: (2012)

Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma
por: Liu, Jun-qi, et al.
Publicado: (2015)

High glucose induces Drp1-mediated mitochondrial fission via the Orai1 calcium channel to participate in diabetic cardiomyocyte hypertrophy
por: Wu, Qing-Rui, et al.
Publicado: (2021)

Immunohistochemical comparison of cyclin D1 and P16 in odontogenic keratocyst and unicystic ameloblastoma
por: Razavi, Seyed Mohammad, et al.
Publicado: (2013)

Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma
por: Wang, Haoxun, et al.
Publicado: (2019)

Hypomethylation of the cyclin D1 promoter in hepatitis B virus-associated hepatocellular carcinoma
por: Liu, Hui-Hui, et al.
Publicado: (2020)

The Relationships between cyclin D1 Expression and Prognosis of Non-small Cell Lung Cancer
por: ZHU, Jiping, et al.
Publicado: (2010)

NAP1L5 Promotes Nucleolar Hypertrophy and Is Required for Translation Activation During Cardiomyocyte Hypertrophy
por: Guo, Ningning, et al.
Publicado: (2021)

Inhibition of the CyclinD1 promoter in response to sonic hedgehog signaling pathway transduction is mediated by Gli1
por: Lin, Zhongxiao, et al.
Publicado: (2017)

Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction
por: Ulm, Susanne, et al.
Publicado: (2014)

Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury
por: Gong, Rui, et al.
Publicado: (2023)

Alamandine attenuates hypertension and cardiac hypertrophy in hypertensive rats
por: Liu, Chi, et al.
Publicado: (2018)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

JMJD1A Represses the Development of Cardiomyocyte Hypertrophy by Regulating the Expression of Catalase
por: Zang, Rongjia, et al.
Publicado: (2020)

Metformin attenuates angiotensin II-induced cardiomyocyte hypertrophy by upregulating the MuRF1 and MAFbx pathway
por: Du, Fawang, et al.
Publicado: (2021)

Lactobacillus rhamnosus GR-1 Attenuates Induction of Hypertrophy in Cardiomyocytes but Not through Secreted Protein MSP-1 (p75)
por: Ettinger, Grace, et al.
Publicado: (2017)

Liquiritin Attenuates Angiotensin II-Induced Cardiomyocyte Hypertrophy via ATE1/TAK1-JNK1/2 Pathway
por: Mo, Jiajia, et al.
Publicado: (2022)

Downregulation of miR-193a-3p via targeting cyclin D1 in thyroid cancer
por: Li, Xiao-Jiao, et al.
Publicado: (2020)

MicroRNA-195 Inhibits the Proliferation of Human Glioma Cells by Directly Targeting Cyclin D1 and Cyclin E1
por: Hui, Wang, et al.
Publicado: (2013)

The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC
por: Shi, Yan, et al.
Publicado: (2022)

Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR-17 to regulate cyclinD2 expression
por: Yu, Boshi, et al.
Publicado: (2021)

Cyclin D1 Induces Chromosomal Instability
por: Casimiro, Mathew C., et al.
Publicado: (2012)

Cyclin D1 expression in prostate carcinoma
por: Pereira, R.A., et al.
Publicado: (2014)

Role of cyclin D1 in breast carcinoma
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2013)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

LINE-1 derepression in senescent cells triggers interferon and inflammaging
por: Cecco, Marco De, et al.
Publicado: (2019)

The prognostic significance and value of cyclin D1, CDK4 and p16 in human breast cancer
por: Peurala, Emmi, et al.
Publicado: (2013)

Differential Expression and Prognostic Value of Cytoplasmic and Nuclear Cyclin D1 in Prostate Cancer
por: Cao, Zhi, et al.
Publicado: (2020)

Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophy
por: Tang, Chun-Mei, et al.
Publicado: (2016)

Demethylation and derepression of genomic retroelements in the skeletal muscles of aged mice
por: Min, Byungkuk, et al.
Publicado: (2019)

Caspase-1 regulates Ang II-induced cardiomyocyte hypertrophy via up-regulation of IL-1β
por: Bai, Yunlong, et al.
Publicado: (2018)

Hepatocellular carcinoma–related cyclin D1 is selectively regulated by autophagy degradation system
por: Wu, Shan‐Ying, et al.
Publicado: (2018)

Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues
por: Lin, Xinsheng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k6jhh68938a7iv4mhemkf33jgc